| Metric | Q2 2025 | Q1 2025 | Q2 2024 | QoQ Change | YoY Change |
|---|---|---|---|---|---|
| Revenue | $632M | $593M | $608M | 6.6% | 4.1% |
| Op. Income | $317M | $324M | $290M | -2.2% | 9.4% |
| Gross Margin | 78.7% | 78.0% | 56.7% | 0.7pp | 22.1pp |
| Net Margin | 40.1% | 44.3% | 33.2% | -4.3pp | 6.9pp |
| EPS (Diluted) | $1.84 | $1.84 | $1.31 | 0.4% | 41.1% |
| Free Cash Flow | $383M | $410M | $287M | -6.5% | 33.7% |
| Item | Amount |
|---|---|
| REVENUE | $632M |
| Cost of Revenue | $134M |
| GROSS PROFIT | $498M |
| R&D Expenses | $0 |
| Selling & Marketing | $97M |
| General & Administrative | $26M |
| SG&A Expenses | $123M |
| Other Expenses | $58M |
| Operating Expenses | $181M |
| Cost & Expenses | $315M |
| OPERATING INCOME | $317M |
| Interest Income | $333M |
| Interest Expense | $0 |
| Other Income/Expenses | $0 |
| INCOME BEFORE TAX | $317M |
| Income Tax Expense | $65M |
| Net Income from Continuing Ops | $253M |
| Net Income from Discontinued Ops | $0 |
| Other Adjustments | $0 |
| NET INCOME | $253M |
| Net Income Deductions | $0 |
| BOTTOM LINE NET INCOME | $253M |
| D&A | $0 |
| EBIT | $317M |
| EBITDA | $317M |
| EPS | $2 |
| EPS Diluted | $2 |
| Item | Amount |
|---|---|
| REVENUE | $632M |
| Cost of Revenue | $134M |
| GROSS PROFIT | $498M |
| R&D Expenses | $0 |
| Selling & Marketing | $97M |
| General & Administrative | $26M |
| SG&A Expenses | $123M |
| Other Expenses | $58M |
| Operating Expenses | $181M |
| Cost & Expenses | $315M |
| OPERATING INCOME | $317M |
| Interest Income | $333M |
| Interest Expense | $0 |
| Other Income/Expenses | $0 |
| INCOME BEFORE TAX | $317M |
| Income Tax Expense | $65M |
| Net Income from Continuing Ops | $253M |
| Net Income from Discontinued Ops | $0 |
| Other Adjustments | $0 |
| NET INCOME | $253M |
| Net Income Deductions | $0 |
| BOTTOM LINE NET INCOME | $253M |
| D&A | $0 |
| EBIT | $317M |
| EBITDA | $317M |
| EPS | $2 |
| EPS Diluted | $2 |
| Item | Amount |
|---|---|
| Net Income | $253M |
| Depreciation & Amortization | $0 |
| Stock-Based Compensation | $17M |
| Deferred Income Tax | $0 |
| Other Non-Cash Items | $112M |
| Change in Working Capital | $0 |
| OPERATING CASH FLOW | $383M |
| Capital Expenditure | $0 |
| Acquisitions (Net) | $0 |
| Purchases of Investments | $0 |
| Sales/Maturities of Investments | $0 |
| Other Investing Activities | -$1.2B |
| NET CASH FROM INVESTING | -$1.2B |
| Net Debt Issuance | $0 |
| Common Stock Repurchased | $0 |
| Common Dividends Paid | $0 |
| Other Financing Activities | $292M |
| NET CASH FROM FINANCING | $292M |
| FREE CASH FLOW | $383M |
| Net Change in Cash | -$526M |
| Item | Amount |
|---|---|
| Cash & Equivalents | $773M |
| Short-Term Investments | $717M |
| Net Receivables | $341M |
| Inventory | $0 |
| Other Current Assets | $427M |
| TOTAL CURRENT ASSETS | $2.3B |
| PP&E (Net) | $73M |
| Goodwill | $6M |
| Intangible Assets | $140M |
| Long-Term Investments | $5.5B |
| Tax Assets | $188M |
| Other Non-Current Assets | $564M |
| TOTAL NON-CURRENT ASSETS | $6.4B |
| TOTAL ASSETS | $8.7B |
| Account Payables | $0 |
| Short-Term Debt | $214M |
| Deferred Revenue | $0 |
| Other Current Liabilities | $0 |
| TOTAL CURRENT LIABILITIES | $3.3B |
| Long-Term Debt | $710M |
| Deferred Revenue NC | $0 |
| Deferred Tax Liabilities | $86M |
| Other Non-Current Liabilities | $1.1B |
| TOTAL NON-CURRENT LIABILITIES | $1.9B |
| TOTAL LIABILITIES | $5.2B |
| Common Stock | $0 |
| Additional Paid-In Capital | $0 |
| Retained Earnings | $0 |
| Treasury Stock | $0 |
| Accum. Other Comp. Income | $0 |
| Other Equity | $3.5B |
| TOTAL STOCKHOLDERS' EQUITY | $3.5B |
| Minority Interest | $7M |
| TOTAL EQUITY | $3.5B |
| TOTAL LIABILITIES & EQUITY | $8.7B |
| Total Debt | $924M |
| Net Debt | $151M |
